Denis Schewe

14PUBLICATIONS

49CO-AUTHORS

Infant and child healthHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|May 27, 2026

Safety of Telemedicine Follow-Up Visits in Children With Cancer Undergoing Intensive Chemotherapy: Results From the Randomized KULT-SH Trial.

|Oct 20, 2025

Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemia.

Sandra Küchler, Silke Brilloff, Silvia Schäfer

|Mar 22, 2024

The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis.

Lennart Lenk, Irène Baccelli, Anna Laqua

|Oct 16, 2023

Recurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL.

Željko Antić, Alena van Bömmel, Konstantin Riege

|Nov 21, 2022

Isocitrate dehydrogenase 1 mutation drives leukemogenesis by PDGFRA activation due to insulator disruption in acute myeloid leukemia (AML).

Sophie Steinhäuser, Patricia Silva, Lennart Lenk

|Nov 27, 2021

Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved Diagnostics.

Philippe Chouvarine, Željko Antić, Jana Lentes

Pageof 3

Frequent Collaborators

Lennart Lenk

Irmela Jeremias

Željko Antić

Anke K Bergmann

Christina Halsey

Ameera Alsadeq

Hassan Jumaa

Martin Schrappe

Beat C Bornhauser

Lorenz Bastian

Frequent Collaborators

Lennart Lenk

Irmela Jeremias

Željko Antić

Anke K Bergmann